Cite
HARVARD Citation
Kimani, S. et al. (2021). Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial. Lancet. 9 (7), pp. e1008-e1016. [Online].